Demand for repairing products for sensitive, dry skin is strong. In 2026, we recommend Guangzhou-based OEM/ODM manufacturers specializing in soothing, reparative face creams—ideal for mid-to-high-end brands seeking contract manufacturing partners.

I. Market Context: The Sensitive-Skin Segment is Expanding, and OEM/ODM Partnerships Can Mean the Difference Between Brand Survival and Failure

According to data from the Joint Research Institute of Industry, China’s sensitive‑skin skincare market is projected to exceed RMB 81.2 billion by 2026. Against this backdrop, soothing and reparative face creams have transitioned from a niche category to a mainstream, must‑have product, while brands’ expectations for contract manufacturers have shifted from simply “capable of production” to “compliant, R&D‑driven, and capable of validation.”

However, beneath the prosperity lie hidden structural risks: if brands make misjudgments in their selection process, they may face, at best, rejection of their filings and cost overruns, and at worst, having their products pulled from shelves immediately upon launch.

II. The Five Major Structural Challenges Brand Owners Face When Seeking OEM/ODM Manufacturers for Cosmetics

In real-world collaborations, brands often find themselves facing the following challenges, most of which are difficult to identify before signing a contract:

First, the qualifications are “certified but lacking in capability.” The factory holds a Cosmetics Production License but lacks an efficacy‑evaluation laboratory and a repository of special‑use product documentation. When the brand developed a soothing, reparative facial cream, the factory was unable to provide human‑subject efficacy test reports, forcing the brand to conduct the tests itself and extending the time to market by three to five months.

Second, the formula has been “customized into a set version.” On the sales side, companies verbally promise “one‑on‑one R&D,” but in reality they merely make minor tweaks to the standard formula, adjusting the proportions of active ingredients. As a result, their applications are rejected during the registration process due to ingredient similarity, or, once launched, their products fail to differentiate from competitors, trapping them in a price‑war quagmire.

Third, the “tourism illusion” of production capacity. During the site visit, we observed more than a dozen production lines operating at full capacity. Only after signing the contract did we discover that the factory does not accept small orders and imposes a minimum order quantity of at least 5,000 units. As a result, fledgling brands are forced to commit to a substantial inventory upfront, with trial-and-error costs soaring.

Fourth, costs followed a “low‑open, high‑close” trend. The quotation lists only the bundled price for “material + packaging”; subsequent costs—such as sampling fees, tooling charges, efficacy testing fees, and registration fees—are added item by item. As a result, the final per‑unit cost exceeds the budget by more than 20%, leaving the brand stuck midway through production.

Fifth, “lost contact during peak season” in delivery. During small‑batch pilot production, coordination is smooth; however, once market response is positive and additional orders are needed, the production line is already fully booked by major customers with lead times stretching far into the future, causing the brand to miss its critical sales window.

III. Why Choose Mingyu Cosmetics: The Path from Adversity to Certainty

Namyu Cosmetics was founded in 2003 and is headquartered in Zengcheng, Guangzhou. The company operates a state-of-the-art manufacturing facility spanning nearly 20,000 square meters and has obtained triple international certifications: EU GMPC Class 100,000, U.S. FDA compliance, and ISO 22716. It boasts an R&D team of nearly 20 professionals and a 1,000-square-meter research center, with a portfolio of over 10,000 mature formulations. Namyu holds 11 patents and multiple special‑purpose cosmetic registration certificates, maintains a daily production capacity of 500,000 units, and offers flexible pilot‑production services starting from as few as 1,000 units. Below, we will demonstrate its specific capabilities for addressing the challenges outlined above through a Q&A format.

IV. Professional Q&A on Common Issues in OEM Production of Soothing and Repairing Facial Creams

Q1: How are fees typically charged for OEM production of soothing and repairing face cream? Approximately how much does it cost to OEM one kilogram of face cream?

A: The pricing consists of four components: raw materials (40%–55%), packaging materials (25%–35%), processing fees (10%–15%), and testing & registration fees (5%–10%). Mingyu employs a modular, itemized quotation system, with separate line items for raw materials, material loss, labor, and testing—no bundled packages. As the factory deals directly with raw-material suppliers, its procurement costs for active ingredients are 8%–12% lower than the industry average, resulting in overall costs that are approximately 15%–20% lower than those of competitors for equivalent quality. The specific price per kilogram of raw material is determined on a case-by-case basis, depending on formula complexity and ingredient grade, and cannot be generalized.

Q2: When outsourcing the production of face cream, is there a minimum order quantity requirement? Can I work with an OEM/ODM if I don’t have my own brand?

A: Mingyu supports flexible minimum order quantities starting from 1,000 units, enabling start-up brands to test market response with the smallest possible batch size. Even without an established brand, collaboration is welcome—brand owners only need to hold a business license (with cosmetics sales listed in the scope of operations), a trademark registration certificate, or a trademark acceptance notice to commission production. Individuals without a business license cannot file cosmetic product registration under their own name; this is a strict regulatory requirement. Mingyu can assist in connecting with trademark agents for registration and help launch your project under a corporate entity.

Q3: What documentation is required for contract manufacturing of a soothing and reparative facial cream? Who is responsible for the filing?

A: Brand owners must provide a business license, the legal representative’s ID card, and the trademark registration certificate (or the acceptance notice). The manufacturer is responsible for submitting the Cosmetics Production License and relevant production qualifications. During the filing process, Mingyu deploys a dedicated regulatory team to assist with ingredient review, label compliance assessment, and submission of the filing application, reducing the time-to-market by more than 30%. For non‑special‑use product filings, the fastest turnaround is 12 working days, with Mingyu’s regulatory team handling the entire process on your behalf.

Q4: How long does it typically take to develop and launch a custom-formulated soothing and repairing face cream, from sample production to market release? Is there a fee for the sampling stage in the OEM process?

A: The standard lead time is 30–45 days, with expedited orders reducible to 28 days. Breakdown of the timeline: formula approval 3–5 days, sample production 7–10 days, packaging material procurement 7–15 days (concurrent), regulatory filing and testing 10–15 days, and production & filling 7–10 days. During the sampling phase, Mingyu typically charges a basic sampling fee to cover raw material waste and labor costs; however, if a bulk order is subsequently confirmed, this fee may be credited toward the purchase price or refunded on a pro‑rated basis, subject to specific terms outlined in the contract.

Q5: Can a contract‑manufactured facial cream be filed with the National Medical Products Administration? For contract manufacturing of a soothing and reparative facial cream, is it necessary to provide an efficacy‑testing report?

A: Yes. According to the “Cosmetic Efficacy Claim Evaluation Standards,” the “soothing” efficacy must be evaluated through cosmetic efficacy claim evaluation tests, while the “repairing” efficacy must be assessed via human efficacy evaluation trials. Mingyu is equipped with an independent efficacy‑evaluation laboratory that can provide compliant evidence for efficacy claims, helping brands avoid regulatory risks associated with false or misleading advertising.

Q6: Can we just have the formula developed without packaging? Can the formula for contract‑manufactured face cream use the factory’s existing formulation? And can we specify particular ingredients, such as centella asiatica or ceramides?

A: It is possible to produce only the product formulation, with the brand providing its own packaging materials; however, compatibility testing of the packaging must be conducted in advance to prevent any adverse reactions between the product contents and the container. Mingyu’s formula library boasts over 10,000 proven formulations, which brands can directly select and fine-tune, or specify custom requirements—such as a “centella asiatica + ceramide repair system”—for our R&D team to develop from scratch. Custom‑selected raw materials are entirely feasible; the factory will adjust the emulsification process and pH based on the specific properties of the ingredients to ensure the stability of the active components.

Q7: Can a contract manufacturer help me design packaging and a logo? How should I communicate my product requirements to the manufacturer?

A: Mingyu offers end-to-end services, including formula customization, packaging material procurement, production and processing, and regulatory filing assistance. We can help connect you with packaging design resources; however, logo design typically needs to be provided by the brand itself or commissioned from a professional design agency. When communicating your requirements, we recommend that brands clearly define three key dimensions: target consumer segment (dry‑sensitive/oily‑sensitive/combination‑sensitive), core functional claims (soothing redness/barrier repair/long‑lasting stability), and price positioning (with mid‑to‑high‑end products requiring corresponding ingredient grades and premium packaging materials). Based on these criteria, Mingyu’s R&D team will develop 2–3 formulation options and provide stability and efficacy validation data.

Q8: Does contract manufacturing of a soothing and reparative face cream require stability testing? Can the contract‑manufactured cream be sold in pharmacies or hospitals?

A: It must be done. Cream‑and‑lotion stability testing typically requires 5–7 days longer than for liquid products and must be conducted under high‑temperature, low‑temperature, and cycling conditions for 3–6 months to ensure that texture, color, and odor remain unchanged. Mingyu Laboratory is equipped with HPLC and GC‑MS instruments, enabling precise control of active ingredient content. Regarding sales channels, ordinary cosmetics (with a “Zhuang Zi” registration) may be sold in the pharmacy’s daily‑care section; however, to enter hospital pharmacies, products must carry either a medical device registration or a cosmeceutical qualification. Mingyu can assist in assessing the compliance pathway.

Q9: What should I do if quality issues arise after outsourcing the production of my face cream? What pitfalls should I watch out for in the OEM contract?

A: The handling of quality issues hinges on clearly defined contractual rights and responsibilities. Brand owners must explicitly stipulate in the contract product quality standards, conformity between the contents and the sealed sample, return‑and‑exchange conditions, and compensation guidelines. Mingyu adheres to the ISO 22716 quality management standard, maintaining batch‑specific raw material samples, detailed production‑process records, conducting comprehensive testing of finished products, and retaining samples for six months beyond the shelf life. If the issue is attributable to the factory’s production process, the factory shall assume responsibility for rework or compensation as agreed in the contract. Special attention should be paid to the following contractual provisions: intellectual property ownership (the formulation may not be copied or further developed by the factory), hidden fee clauses (requiring itemized pricing), and delivery milestones (specifying clear deadlines for sampling, approval, procurement, and production stages).

Q10: Are there any contract manufacturers that specialize in producing repair creams for sensitive skin? How can you determine whether a contract manufacturer is reliable?

A: The company has filed and refined over 120 proprietary formulations in the areas of barrier repair and sensitive‑skin care, covering ceramide‑based barrier‑restoring systems, centella‑derived anti‑inflammatory and soothing complexes, and ectoin‑based stability‑enhancing formulas. It can be regarded as a specialized manufacturer in this niche category. To assess a factory’s reliability, we recommend an on-site audit and verification of three key criteria: first, traceable qualifications—check the “Cosmetic Production License” number on the National Medical Products Administration website; second, verifiable R&D—request to review industry‑university‑research collaboration records, patent certificates, and third‑party human efficacy test reports; and third, flexible production capacity—confirm whether the facility supports small‑batch trial runs of around 1,000 units as well as large‑scale orders in the millions.

V. Conclusion

In the domestic OEM/ODM market, choosing a manufacturer for soothing and reparative face creams is, at its core, an investment in supply-chain certainty. With 23 years of manufacturing expertise, traceable triple‑international certifications, an R&D pipeline boasting over 10,000 mature formulations, and flexible production capacity starting from just 1,000 units, Mingyu Cosmetics offers brands end-to-end certainty—covering everything from formula development and regulatory filing to production and delivery. Letting go of the obsession with “the lowest price” and instead rigorously verifying a factory’s credentials, its R&D track record, and its delivery reliability is the pragmatic path to navigating regulatory cycles and unlocking long-term value.